Taipei Exchange - Delayed Quote TWD

Sinew Pharma Inc. (6634.TWO)

54.50
+4.10
+(8.13%)
At close: 2:55:51 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
328
6,229
Cost of Revenue
--
--
--
38
1,137
Gross Profit
--
--
--
290
5,092
Operating Expense
168,864
168,864
186,253
148,718
99,512
Operating Income
-168,864
-168,864
-186,253
-148,428
-94,420
Net Non Operating Interest Income Expense
16,249
16,249
15,255
8,098
2,805
Pretax Income
-150,370
-150,370
-170,921
-140,180
-91,575
Net Income Common Stockholders
-150,370
-150,370
-170,921
-140,180
-91,575
Diluted NI Available to Com Stockholders
-150,370
-150,370
-170,921
-140,180
-91,575
Basic EPS
-2.11
--
-2.43
-2.02
-1.54
Diluted EPS
-2.11
--
-2.43
-2.02
-1.54
Basic Average Shares
71,265.40
--
70,337.86
69,298
59,498
Diluted Average Shares
71,265.40
--
70,337.86
69,298
59,498
Total Expenses
168,864
168,864
186,253
148,756
100,649
Net Income from Continuing & Discontinued Operation
-150,370
-150,370
-170,921
-140,180
-91,575
Normalized Income
-150,370
-150,370
-170,921
-140,180
-91,575
Interest Income
16,663
16,663
16,031
8,373
2,951
Interest Expense
414
414
776
275
146
Net Interest Income
16,249
16,249
15,255
8,098
2,805
EBIT
-149,956
-149,956
-170,145
-139,905
-91,429
EBITDA
-119,649
-119,649
-141,160
-117,092
-68,785
Reconciled Cost of Revenue
--
--
--
38
1,137
Reconciled Depreciation
30,307
30,307
28,985
22,813
22,644
Net Income from Continuing Operation Net Minority Interest
-150,370
-150,370
-170,921
-140,180
-91,575
Normalized EBITDA
-119,649
-119,649
-141,160
-117,092
-68,785
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/30/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers